# Phylo partners with Bayer to use Biomni Lab AI platform

> Phylo will give Bayer scientists full access to its agentic AI platform Biomni Lab to help assemble literature and omics data for drug discovery.

Oossa · 2026-10-22 · https://oossa.com/en/phylo-partners-with-bayer-to-use-biomni-lab-ai-platform

Phylo, Inc. announced a partnership with Bayer to deploy Biomni Lab, its agentic AI platform, in Bayer’s research labs. The platform lets scientists pull together scientific papers, biomedical data and analysis methods in one place, cutting manual work. It also keeps a record of each step so researchers can see the sources and methods behind any result. Bayer will use Biomni Lab mainly for literature and omics evidence gathering in drug discovery.

## The facts

- Partnership announced on 2026-10-22
- Biomni Lab provides a unified AI‑agent workspace for literature and omics data

## Why it matters

Bayer scientists can explore more drug‑discovery hypotheses faster by letting AI handle data gathering and workflow tracking.

## Sources & references

1. [Phylo's Biomni Lab to expand the use of AI agents in scientific research at Bayer](https://www.prnewswire.com/news-releases/phylos-biomni-lab-to-expand-the-use-of-ai-agents-in-scientific-research-at-bayer-302917080.html) – PR Newswire RSS, 2026-10-22

Last updated: 2026-10-22